| Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients G Siravegna, B Mussolin, M Buscarino, G Corti, A Cassingena, ... Nature medicine 21 (7), 795-801, 2015 | 1099 | 2015 |
| Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth G Germano, S Lamba, G Rospo, L Barault, A Magrì, F Maione, M Russo, ... Nature 552 (7683), 116-120, 2017 | 560 | 2017 |
| Acquired resistance to the TRK inhibitor entrectinib in colorectal cancer M Russo, S Misale, G Wei, G Siravegna, G Crisafulli, L Lazzari, G Corti, ... Cancer discovery 6 (1), 36-44, 2016 | 297 | 2016 |
| Radiologic and genomic evolution of individual metastases during HER2 blockade in colorectal cancer G Siravegna, L Lazzari, G Crisafulli, A Sartore-Bianchi, B Mussolin, ... Cancer Cell 34 (1), 148-162. e7, 2018 | 137 | 2018 |
| Efficacy of Sym004 in patients with metastatic colorectal cancer with acquired resistance to anti-EGFR therapy and molecularly selected by circulating tumor DNA analyses: a … C Montagut, G Argilés, F Ciardiello, TT Poulsen, R Dienstmann, M Kragh, ... JAMA oncology 4 (4), e175245-e175245, 2018 | 110 | 2018 |
| The clinical impact of the genomic landscape of mismatch repair–deficient cancers G Germano, N Amirouchene-Angelozzi, G Rospo, A Bardelli Cancer discovery 8 (12), 1518-1528, 2018 | 91 | 2018 |
| A subset of colorectal cancers with cross-sensitivity to olaparib and oxaliplatin S Arena, G Corti, E Durinikova, M Montone, NM Reilly, M Russo, ... Clinical Cancer Research 26 (6), 1372-1384, 2020 | 74 | 2020 |
| Werner helicase is a synthetic-lethal vulnerability in mismatch repair–deficient colorectal cancer refractory to targeted therapies, chemotherapy, and immunotherapy G Picco, CM Cattaneo, EJ van Vliet, G Crisafulli, G Rospo, S Consonni, ... Cancer discovery 11 (8), 1923-1937, 2021 | 57 | 2021 |
| Evolving neoantigen profiles in colorectal cancers with DNA repair defects G Rospo, A Lorenzato, N Amirouchene-Angelozzi, A Magrì, C Cancelliere, ... Genome medicine 11, 1-22, 2019 | 47 | 2019 |
| CD4 T cell–dependent rejection of beta-2 microglobulin null mismatch repair–deficient tumors G Germano, S Lu, G Rospo, S Lamba, B Rousseau, S Fanelli, D Stenech, ... Cancer discovery 11 (7), 1844-1859, 2021 | 44 | 2021 |
| Acquired resistance to the TRK inhibitor entrectinib in colorectal cancer. Cancer Discov. 2016; 6: 36–44. doi: 10.1158/2159-8290 M Russo, S Misale, G Wei, G Siravegna, G Crisafulli, L Lazzari, G Corti, ... CD-15-0940.[Abstract][CrossRef][Google Scholar], 0 | 44 | |
| A genomic analysis workflow for colorectal cancer precision oncology G Corti, A Bartolini, G Crisafulli, L Novara, G Rospo, M Montone, ... Clinical colorectal cancer 18 (2), 91-101. e3, 2019 | 36 | 2019 |
| Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer D Oddo, G Siravegna, A Gloghini, C Vernieri, B Mussolin, F Morano, ... British Journal of Cancer 117 (3), 347-352, 2017 | 34 | 2017 |
| DeCoClu: Density consensus clustering approach for public transport data A Fiori, A Mignone, G Rospo Information Sciences 328, 378-388, 2016 | 25 | 2016 |
| Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapies M Russo, S Lamba, A Lorenzato, A Sogari, G Corti, G Rospo, B Mussolin, ... Nature Communications 9 (1), 2287, 2018 | 19 | 2018 |
| Two main mutational processes operate in the absence of DNA mismatch repair E Németh, A Lovrics, JZ Gervai, M Seki, G Rospo, A Bardelli, D Szüts DNA repair 89, 102827, 2020 | 18 | 2020 |
| TRKA expression and NTRK1 gene copy number across solid tumours G Mauri, E Valtorta, G Cerea, A Amatu, M Schirru, G Marrapese, V Fiorillo, ... Journal of Clinical Pathology 71 (10), 926-931, 2018 | 15 | 2018 |
| Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance V Amodio, S Lamba, R Chila, CM Cattaneo, B Mussolin, G Corti, G Rospo, ... Cancer Cell 41 (1), 196-209. e5, 2023 | 10 | 2023 |
| Tracking colorectal cancer evolution in time and space G Rospo, G Corti, G Crisafulli, L Novara, A Bardelli Annals of Oncology 28 (6), 1163-1165, 2017 | 6 | 2017 |
| Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity F Bersani, F Picca, D Morena, L Righi, F Napoli, M Russo, D Oddo, ... Journal of Experimental & Clinical Cancer Research 42 (1), 120, 2023 | 4 | 2023 |
